Diosgenin inhibits hTERT gene expression in the A549 lung cancer cell line

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6945-6948

  Mohammad, Rahmati Yamchi ^a,b,d   Somayyeh, Ghareghomi ^c   Gholamreza, Haddadchi ^c   Majid, Mobasseri ^d   Yousef, Rasmi ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diosgenin; Htert; Lung cancer; Mtt assay; Pcr; Qrt; Telomerase

Indexed keywords

DIOSGENIN; MESSENGER RNA; TELOMERASE; TERT PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LUNG TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADENOCARCINOMA; CELL PROLIFERATION; DIOSGENIN; HUMANS; LUNG NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 84892448366     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6945     Document Type: Article

References (24)

1. Athey V, Suckling R, Tod A, et al (2012). Early diagnosis of lung cancer: evaluation of a community-based social marketing intervention. Thorax, 67, 412-7.
2. Buseman CM, Wright WE, Shay JW, et al (2012). Is telomerase a viable target in cancer? Mutat Res, 730, 90-7.
3. Chen PSh, Shih YW, Huang HCh, et al (2011). Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS One, 6, 20164.
4. Goldkom T, Chung S, Filosto S, et al (2013). Lung cancer and lung injury: the dual role of ceramide. Handb Exp Pharmacol, 216, 93-113.
5. Hamilton W, Peters TJ, Round A, et al (2005). What are the clinical features of lung cancer before the diagnosis is made? A population based case-controlled study. Thorax, 60, 1059-65.
6. Herbst RS, Heymach JV, LippmanSM, et al (2008). Lung cancer. N Engl J Med, 359, 1367-80.
7. Holysz H, Lipinska N, Paszel-Jaworska A, et al (2013). Telomerase as a useful target in cancer fighting- the breast cancer case. Tumor Biol, 34, 1371-80.
8. Hsin IL, Sheu GT, Chen HH, et al (2010). N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells. Mutat Res, 688, 72-7.
9. Kazemi F, Zarghami N, Fekri-aval S, et al (2011). ß-Cyclodextrincurcumin complex inhibit telomerase gene expression in T47-D breast cancer cell line. Afr J Biotechnol, 83, 19481-8.
10. Leger DY, Liagre B, Corbìre C, et al (2004). Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression. Int J Oncol, 25, 555-62.
11. Lepage C, Léger DY, Bertrand J, et al (2011). Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett, 301, 193-202.
12. Li F, Fernandez PP, Rajendran P, et al (2010).Diosgenin, a steroidal saponin, inhibits SATA3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett, 292, 197-207.
13. Miyoshi N, Nagasawa T, Mabuchi R, et al (2011). Chemoprevention of azoxymethane/dextran sodium sulfateinduced mouse colon carcinogenesis by freeze-dried Yam Sanyaku and its constituent diosgenin. Cancer Prev Res, 4, 924-34.
14. Moalic S, Liagre B, Corbìre C, et al (2001). A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett, 506, 225-30.
15. Nagore DH, Patil PS, Kuber VV, et al (2012). Comparison between high performance liquid chromatography and high performance thin layer chromatography determination of diosgenin from fenugreek seeds. IJGP, 6, 315-20.
16. Noel JF, Wellinger R (2012). Exposing secrets of telomeretelomerase encounters. Cell, 150, 453-4.
17. Olaku O, White J (2011). Herbal therapy use by cancer patients:A literature review on case reports. Eur J Cancer, 47, 508-14.
18. Raju J, Patlolla JM, Swamy MV, et al (2004). Diosgenin, a steroid saponin of Trigonellafoenumgraecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev, 13, 1392-8.
19. Sato M, Shin K, Lee JI, et al (2012). Human telomerase reverse transcriptase and glucose-regulated protein 78 increase the life span of articular chondrocytes and their repair potential. BMC Musculoskeletal Disorders, 13, 51.
20. Shishodia S, Aggarwal B (2006). Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IkappaB kinase activation and NFkappaB- regulated gene expression. Oncogene, 25, 1463-73.
21. Sprouse AA, Steding CE, Herbert BS, et al (2012). Pharmaceutical regulation of telomerase and its clinical potential. J Cell, 16, 1-7.
22. Wojtyla A, Gladych M, Rubis B, et al (2011).Human telomerase activity regulation. Mol Biol Rep, 38, 3339-49.
23. Xiao X, Sidorov IA, Gee J, et al (2005). Retinoic acid induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol, 79, 108-17.
24. Yan LL, Zhang YJ, Gao WY, et al (2009). In vitro and in vivo anticancer activity of steroid saponinsof Parispolyphylla var. yunnanensis. Exp Oncol, 31, 27-32.